Sun, Yinming
Blumberger, Daniel M.
Mulsant, Benoit H.
Rajji, Tarek K.
Fitzgerald, Paul B.
Barr, Mera S.
Downar, Jonathan http://orcid.org/0000-0002-5140-174X
Wong, Willy
Farzan, Faranak
Daskalakis, Zafiris J.
Article History
Received: 27 September 2017
Revised: 5 May 2018
Accepted: 5 June 2018
First Online: 23 November 2018
Conflict of interest
: D.M.B. received research support from CIHR, National Institutes of Health (NIH), Brain Canada, Temerty Family through the CAMH Foundation and the Campbell Family Research Institute. He received non-salary operating funds and in-kind equipment support from Brain Research and Development Services Ltd. for an investigator-initiated study. He is the site principal investigator for several sponsor-initiated clinical trials from Brain Research and Development Services Ltd. He received in-kind equipment support from Tonika/MagVenture for an investigator-initiated study. B.H.M. received research support from CIHR, NIH, Bristol-Myers Squibb (medications for an NIH-funded clinical trial), and Pfizer (medications for an NIH-funded clinical trial). He directly owns stocks of General Electric (<$5000). Within the past 5 years, he has also received some grant support from Eli Lilly (medications for an NIH-funded clinical trial) and Janssen, and some travel support from Roche. T.K.R. received research support from NARSAD, Canadian Foundation for Innovation, CIHR, Ontario Ministry of Health and Long-Term Care, Ontario Ministry of Research and Innovation, and the W Garfield Weston Foundation. P.B.F. received in the past 2 years equipment for research from Brainsway, Medtronic, and MagVenture A/S, and funding for research from Cervel Neurotech. M.B. received research support from NARSAD. J.D. received research support from the CIHR, Brain Canada, the NIH, the Klarman Family Foundation, the Edgestone Foundation, and the Toronto General and Western Hospital Foundation as well as travel stipends from Lundbeck and ANT Neuro and in-kind equipment support for an investigator-initiated study from MagVenture. F.F. received research support from NARSAD and Natural Sciences and Engineering Research Council of Canada (NSERC). In the last 3 years, Z.J.D. has received research and equipment in-kind support for an investigator-initiated study through Brainsway Inc and Magventure Inc. Z.J.D. has also received monies for participation on an advisory board from Sunovion Inc. This work was supported by the Ontario Mental Health Foundation (OMHF), the Canadian institutes of Health Research (CIHR), the Brain and Behaviour Research Foundation and the Temerty Family and Grant Family and through the Centre for Addiction and Mental Health (CAMH) Foundation and the Campbell Institute. All the remaining authors declare that they have no conflict of interest.